Clinical Trial Update: Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating capecitabine, oxaliplatin, and radiation therapy for stage II/III anal cancer has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-04-17